[go: up one dir, main page]

MA30568B1 - Precurseurs de medicaments du type peneme - Google Patents

Precurseurs de medicaments du type peneme

Info

Publication number
MA30568B1
MA30568B1 MA31512A MA31512A MA30568B1 MA 30568 B1 MA30568 B1 MA 30568B1 MA 31512 A MA31512 A MA 31512A MA 31512 A MA31512 A MA 31512A MA 30568 B1 MA30568 B1 MA 30568B1
Authority
MA
Morocco
Prior art keywords
type
peneme
precursors
abstract
drug precursors
Prior art date
Application number
MA31512A
Other languages
English (en)
Inventor
Katherine Elizabeth Brighty
Anthony Marfat
Dale Gordon Mcleod
John Paul O'donnell
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of MA30568B1 publication Critical patent/MA30568B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/88—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/887—Compounds with a double bond between positions 2 and 3 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with a hetero atom or a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

DEPOSANT Société dite : PFIZER PRODUCT INC. REVENDICATION DE PRIORITES 28/06/2006 US 60/806000 13/04/2007 US 60/911587 Voir en annexe le titre de l'invention et le texte de l'abrégé Précurseurs de médicaments du type pénème Des précurseurs, doués de biodisponibilité orale, de médicaments du type sulopénème, par exemple (I) et leurs produits de solvatation et hydrates, leur préparation, leur formulation, et l'utilisation pour traiter et prévenir une infection chez des mammifères tels que les êtres humains. Cet abrégé ne limite pas l'invention.
MA31512A 2006-06-28 2008-12-26 Precurseurs de medicaments du type peneme MA30568B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80600006P 2006-06-28 2006-06-28
US91158707P 2007-04-13 2007-04-13

Publications (1)

Publication Number Publication Date
MA30568B1 true MA30568B1 (fr) 2009-07-01

Family

ID=38463109

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31512A MA30568B1 (fr) 2006-06-28 2008-12-26 Precurseurs de medicaments du type peneme

Country Status (28)

Country Link
US (2) US7795243B2 (fr)
EP (1) EP2044085B1 (fr)
JP (2) JP4397435B2 (fr)
KR (1) KR101060448B1 (fr)
AP (1) AP2008004705A0 (fr)
AR (1) AR061646A1 (fr)
AT (1) ATE493419T1 (fr)
AU (1) AU2007263519B2 (fr)
BR (1) BRPI0712740A2 (fr)
CA (1) CA2655485C (fr)
CL (1) CL2007001910A1 (fr)
CR (1) CR10467A (fr)
DE (1) DE602007011622D1 (fr)
DK (1) DK2044085T3 (fr)
EA (1) EA200870584A1 (fr)
EC (1) ECSP088947A (fr)
GT (1) GT200700050A (fr)
IL (1) IL195383A0 (fr)
MA (1) MA30568B1 (fr)
MX (1) MX2009000116A (fr)
NL (1) NL2000715C2 (fr)
NO (1) NO20090392L (fr)
PE (1) PE20080940A1 (fr)
SV (1) SV2008003139A (fr)
TN (1) TNSN08537A1 (fr)
TW (1) TW200816999A (fr)
UY (1) UY30439A1 (fr)
WO (1) WO2008001212A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug
WO2009108704A1 (fr) * 2008-02-25 2009-09-03 Semafore Pharmaceuticals, Inc. Combinaison de promédicaments inhibiteurs de pi-3 kinase o-alkylés
KR100916052B1 (ko) 2009-02-24 2009-09-08 코오롱건설주식회사 진공이송 쓰레기 수거시스템의 쓰레기 배출밸브
KR20120087878A (ko) * 2009-08-10 2012-08-07 비에이치아이 리미티드 파트너쉽 1,3-프로판디설포닉 애시드의 수송을 위한 방법, 화합물 및 조성물
US11554112B2 (en) * 2018-06-07 2023-01-17 Herum Therapeutics International Limited Combinations of β-lactam compounds and probenecid and uses thereof
WO2020164788A1 (fr) * 2019-02-13 2020-08-20 Iterum Therapeutics International Limited Combinaisons de composés bêta-lactame et de probénécide et leurs utilisations

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4619924A (en) 1984-05-18 1986-10-28 Pfizer Inc. 2-alkylthiopenem derivatives
US4870170A (en) * 1985-10-17 1989-09-26 Pfizer Inc. Process for 2-(1-oxo-3-thiolanyl)-2-penem antibiotics
WO1988008845A1 (fr) 1987-05-11 1988-11-17 Pfizer Inc. Acides diastereomeres 5r,6s-6-(1r-hydroxyethyle)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxyliques
GB8713515D0 (en) 1987-06-10 1987-07-15 Erba Farmitalia Methoxymethyl compounds
US4874877A (en) * 1988-04-19 1989-10-17 Pfizer Inc. Process for optically active 3-(methane-sulfonyloxy)thiolane and analogs
AU8333991A (en) 1990-08-20 1992-03-17 Suntory Limited Penem compounds
JP3148235B2 (ja) 1990-08-20 2001-03-19 サントリー株式会社 抗菌性ペネム化合物
WO2004067532A1 (fr) 2003-01-31 2004-08-12 Meiji Seika Kaisha, Ltd. Nouveaux dérivés de carbapenem
PE20080940A1 (es) * 2006-06-28 2008-07-09 Pfizer Prod Inc Profarmacos de penem
US20080015494A1 (en) * 2006-07-11 2008-01-17 Microchips, Inc. Multi-reservoir pump device for dialysis, biosensing, or delivery of substances
US20080125408A1 (en) * 2006-11-14 2008-05-29 Pfizer Inc Penem prodrug

Also Published As

Publication number Publication date
NL2000715C2 (nl) 2008-03-11
EP2044085B1 (fr) 2010-12-29
NL2000715A1 (nl) 2008-01-02
PE20080940A1 (es) 2008-07-09
ECSP088947A (es) 2009-01-30
CA2655485A1 (fr) 2008-01-03
TW200816999A (en) 2008-04-16
SV2008003139A (es) 2010-01-12
EA200870584A1 (ru) 2009-06-30
MX2009000116A (es) 2009-01-23
US20080009474A1 (en) 2008-01-10
CL2007001910A1 (es) 2008-01-11
UY30439A1 (es) 2008-01-31
US20090042853A1 (en) 2009-02-12
JP2009542616A (ja) 2009-12-03
EP2044085A2 (fr) 2009-04-08
KR101060448B1 (ko) 2011-08-29
JP4397435B2 (ja) 2010-01-13
DK2044085T3 (da) 2011-03-07
KR20090015147A (ko) 2009-02-11
AR061646A1 (es) 2008-09-10
JP5152527B2 (ja) 2013-02-27
IL195383A0 (en) 2009-08-03
CA2655485C (fr) 2011-08-02
TNSN08537A1 (fr) 2010-04-14
NO20090392L (no) 2009-01-27
US7795244B2 (en) 2010-09-14
HK1134928A1 (en) 2010-05-20
AU2007263519A1 (en) 2008-01-03
BRPI0712740A2 (pt) 2012-06-05
GT200700050A (es) 2008-02-01
ATE493419T1 (de) 2011-01-15
AP2008004705A0 (en) 2008-12-31
AU2007263519B2 (en) 2011-05-19
DE602007011622D1 (en) 2011-02-10
JP2010013468A (ja) 2010-01-21
WO2008001212A2 (fr) 2008-01-03
CR10467A (es) 2009-01-19
US7795243B2 (en) 2010-09-14
WO2008001212A3 (fr) 2008-03-20

Similar Documents

Publication Publication Date Title
MA30568B1 (fr) Precurseurs de medicaments du type peneme
UA95715C2 (ru) Фосфадиазиновые производные, фармацевтическая композиция и их применение
MA33218B1 (fr) Applications therapeutiques de derives de quinazolinedione
EE200200207A (et) Kinoliiniderivaatide kasutamine vähivastase ravimi valmistamiseks, ühendite saamine ning neid sisaldavad farmatseutilised kompositsioonid
WO2009121063A3 (fr) Modulateurs du récepteur de la chimiokine
MY145074A (en) Thiazolidin-4-one derivatives
NZ588913A (en) Liver cancer drug
NO20042596L (no) Inbibitorer av 11-beta-hydroksy steroid dehydrogenase type 1
MX2009010289A (es) Composiciones para administracion nasal.
MA29791B1 (fr) Composes therapeutiques.
AU2002307049A1 (en) Use of mglur5 antagonists in the manufacture of a medicament in the treatment of autism, mental retardation, schizophrenia
WO2008020306A3 (fr) Dérivés d'isoindole
ES2186550A1 (es) Nuevos derivados de oxazolidinonas como antibacterianos.
GEAP202515762A (en) Pyrrole compounds
TW200800931A (en) Novel piperazines as antimalarial agents
GEP20257744B (en) Antimalarial agents
MA33254B1 (fr) Applications thérapeutiques dans le domaine cardiovasculaire de dérivés de quinazolinedione
MX2021014830A (es) Conjugados de compuestos que comprenden nitrogeno heteroaromatico donador de pares de electrones pi.
ATE360428T1 (de) Analgetisches arzneimittel
MXPA05012679A (es) Nuevos derivados de imidazoles, su preparacion y su uso como medicamento.
PH12021550878A1 (en) Cyclodextrin-based formulation of a bcl-2 inhibitor
CO5251446A1 (es) Mezcla de linezolid y otros agentes antibacterianos
DE50204789D1 (de) Neue 1-amidomethylcarbonyl-piperidinderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
AU4568400A (en) Sphingomyelinase inhibitor
EP4355259A4 (fr) Plateau sous-gingival d'administration de médicaments